Live Breaking News & Updates on Professor Gary Wong Ka Leung

Stay updated with breaking news from Professor gary wong ka leung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hong Kong unveils next-gen drug for cancers associated with Epstein–Barr virus

Hong Kong unveils next-gen drug for cancers associated with EpsteinâBarr virus
Hong Kong unveils next-gen drug for cancers associated with EpsteinâBarr virus
03 March 2021 | News
HKBU has established a spin-off company named BP InnoMed Limited (BPI) to further develop this new anti-EBV drug and carry out clinical trials
Source: PR Newswire
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein–Barr virus (EBV).
The peptide-linked drug, which is responsive to the acidic environment found in tumours, is the first known agent to have successfully targeted two viral proteins that are simultaneously produced by EBV. ....

Hong Kong , Hong Lok , A Hong Kong , Gary Wong Ka Leung , Department Of Chemistry , Department Of Applied Biology , Hong Kong Polytechnic University , Sun Yat Sen University , Chemical Technology , Bp Innomed Limited , Baptist University Led , Assistant Professor , Law Ga Lai , Associate Professor , Applied Biology , Med Limited , Third Affiliated Hospital , Sun Yat Sen , Hong Kong Baptist University , Epstein Barr Virus , Professor Gary Wong Ka Leung , Cancer Drug , Tumour Cell , ஹாங் காங் , ஹாங் லோக் , ஹாங் காங் ,

HKBU develops dual-targeting drug for EBV-related cancers

Hong Kong Baptist University
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has thepotential to become a
next-generation treatment for cancers associated with Epstein–Barr virus (EBV).
The peptide-linked drug, which is responsive to the acidic environment found in tumours, is the first known agent to have
successfully targeted two viral proteins that are simultaneously produced by EBV. It also offers a new strategy by increasing the uptake of anti-cancer drugs in tumour cells, thus
allowing the application of lower drug dosages which helps reduce treatment side effects and health risks.
The research results were published in the international academic journal ....

Hong Kong , Hong Lok , Gary Wong Ka Leung , Third Affiliated Hospital At Sun Yat Sen University , Hong Kong Polytechnic University , Chemical Technology , Incu Bio Program Of The Hong Kong Science , Bp Innomed Limited , Head Of The Department Chemistry , Asian Fund For Cancer Research , Technology Park , Professor Of The Department Applied Biology , Professor Of The Department Chemistry , Hong Kong Baptist University Led , Professor Gary Wong Ka Leung , Assistant Professor , Associate Professor , Applied Biology , Med Limited , Best Public Communicator , Cancer Entrepreneurship Venture Competition , Asian Fund , Incu Bio Program , Hong Kong Science , Third Affiliated Hospital , Sun Yat Sen ,

Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

Hong Kong , Hong Lok , Gary Wong Ka Leung , Emily Henderson , Hong Kong Polytechnic University , Head Of The Department Chemistry , Chemical Technology , Professor Of The Department Applied Biology , Professor Of The Department Chemistry , Hong Kong Baptist University Led , Professor Gary Wong Ka Leung , Assistant Professor , Associate Professor , Applied Biology , Wong Ka Leung , ஹாங் காங் , ஹாங் லோக் , கேரி வோங் கா லேஉங் , எமிலி ஹென்டர்சன் , ஹாங் காங் பாலிடெக்நிக் பல்கலைக்கழகம் , தலை ஆஃப் தி துறை வேதியியல் , இரசாயன தொழில்நுட்பம் , ப்ரொஃபெஸர் ஆஃப் தி துறை பயன்படுத்தப்பட்டது உயிரியல் , ப்ரொஃபெஸர் ஆஃப் தி துறை வேதியியல் , ஹாங் காங் ஞானஸ்நானம் பல்கலைக்கழகம் வழிநடத்தியது , ப்ரொஃபெஸர் கேரி வோங் கா லேஉங் ,

HKBU develops dual-targeting drug for EBV-related cancers

HKBU develops dual-targeting drug for EBV-related cancers
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Hong Kong , Kostenloser Wertpapierhandel , Hong Lok , Gary Wong Ka Leung , Third Affiliated Hospital At Sun Yat Sen University , Hong Kong Polytechnic University , Chemical Technology , Incu Bio Program Of The Hong Kong Science , Bp Innomed Limited , Asian Fund For Cancer Research , Head Of The Department Chemistry , Technology Park , Professor Of The Department Applied Biology , Professor Of The Department Chemistry , Public Relations Office , Hong Kong Baptist University Led , Professor Gary Wong Ka Leung , Assistant Professor , Associate Professor , Applied Biology , Med Limited , Best Public Communicator , Cancer Entrepreneurship Venture Competition , Asian Fund , Incu Bio Program , Hong Kong Science ,

HKBU develops dual-targeting drug for EBV-related cancers

HKBU develops dual-targeting drug for EBV-related cancers
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , Hong Lok , Gary Wong Ka Leung , Third Affiliated Hospital At Sun Yat Sen University , Hong Kong Polytechnic University , Hong Kong Baptist University , Chemical Technology , Incu Bio Program Of The Hong Kong Science , Bp Innomed Limited , Head Of The Department Chemistry , Asian Fund For Cancer Research , Technology Park , Professor Of The Department Applied Biology , Public Relations Office , Professor Of The Department Chemistry , Professor Gary Wong Ka Leung , Assistant Professor , Associate Professor , Applied Biology , Med Limited , Best Public Communicator , Cancer Entrepreneurship Venture Competition , Asian Fund , Incu Bio Program , Hong Kong Science , Third Affiliated Hospital ,